<DOC>
	<DOCNO>NCT01776385</DOCNO>
	<brief_summary>Malignant pleural mesothelioma ( MPM ) grow incidence spite early diagnostic , outcome remain dismal . The evolution MPM often local rare distant metastasis . There sizable body evidence metastasis could develop circulate tumor cell ( CTC ) spread blood surgery . Thus , sensitive specific detection CTC blood consider potentially relevant predictive biomarker patient carcinomas . In exchange , prognostic value CTC MPM yet evaluate . Indeed , main goal preoperative detection CTC identify patient high risk recurrence surgery , order perform adapt therapeutic strategy . Despite several study report CTC detection , methodological aspect concern sensitivity , specificity reproducibility prevent clear appraisal clinical impact . Thus , aim study evaluate presence prognostic value CTC MPM double approach . In set , cytopathological analysis circulate non hematological cell ( CNHC ) , epithelial origin , isolate accord size ( ISET , Isolation Size Epithelial Tumor cell ) along immunomagnetic selection , identification enumeration circulate epithelial cell peripheral blood ( CellSearch method ) consider promising approach .</brief_summary>
	<brief_title>The ISET ( Isolation Size Epithelial Tumor Cells ) CellSearch Methods Malignant Pleural Mesothelioma</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Pneumothorax</mesh_term>
	<mesh_term>Parathyroid Neoplasms</mesh_term>
	<mesh_term>Pleural Neoplasms</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>Inclusion Criteria For patient : Age &gt; 18 year Patient operate strong suspicion pleural malignant tumoral lesion correspond primitive pleural mesothelioma Signed patient consent For control subject : Age &gt; 18 year unhurt malignant mild tumoral pathology patient must benefit surgical procedure benign lesion organ pleura pulmonary non tumoral lesion Signed patient consent Exclusion Criteria : Patient history cancer synchronous cancer Patient additives treatment Patient accord treatment additives others protocol codify ( particular , platinum navelbine gemcitabine platinum ) stag II HIV , hepatitis B C infection Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>[ C08.785.640 ]</keyword>
	<keyword>( C08.528.778 )</keyword>
	<keyword>[ C19.642.713 ]</keyword>
	<keyword>mesothelium</keyword>
</DOC>